Danel (Adir Yeoshua) Ltd (TLV:DANE)
42,770
+270 (0.64%)
Aug 28, 2026, 1:47 PM IDT
Danel (Adir Yeoshua) Revenue
Danel (Adir Yeoshua) had revenue of 761.45M ILS in the quarter ending June 30, 2026, with 6.69% growth. This brings the company's revenue in the last twelve months to 2.98B, up 5.54% year-over-year. In the year 2025, Danel (Adir Yeoshua) had annual revenue of 2.90B with 5.26% growth.
Revenue (ttm)
2.98B
Revenue Growth
+5.54%
P/S Ratio
0.85
Revenue / Employee
694.57K
Employees
4,288
Market Cap
2.53B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.90B | 145.18M | 5.26% |
| Dec 31, 2024 | 2.76B | 259.93M | 10.40% |
| Dec 31, 2023 | 2.50B | 135.37M | 5.73% |
| Dec 31, 2022 | 2.36B | 75.20M | 3.29% |
| Dec 31, 2021 | 2.29B | 303.89M | 15.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 51.58B |
| Amal Holdings A.D. | 2.18B |
| Novolog (Pharm-Up 1966) | 1.81B |
| Ilex Medical | 885.35M |
| Kamada | 571.54M |
| SofWave Medical | 310.85M |
| InterCure | 270.20M |
| BrainsWay | 180.82M |